...
首页> 外文期刊>Experimental Physiology >A(1)-Adenosine receptor activation has biphasic roles in development of acute kidney injury at 4 and 24 h of reperfusion following ischaemia in rats
【24h】

A(1)-Adenosine receptor activation has biphasic roles in development of acute kidney injury at 4 and 24 h of reperfusion following ischaemia in rats

机译:A(1)-腺苷受体激活在大鼠缺血再灌注4和24小时后急性肾损伤的发展中具有双相作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We previously reported that selective blockade of the A(1)-adenosine receptor (A(1)AR) with an antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), had protective effects on renal ischaemia-induced structural and functional disruption during a 4 h reperfusion period. In contrast, several studies demonstrated that endogenous and exogenous A1AR activation before renal ischaemia had a renoprotective role 24 h after reperfusion, through mechanisms that reduced inflammation, necrosis and apoptosis. In this study, we investigated potential mechanisms underlying this biphasic action of A(1)AR in renal ischaemia-reperfusion injury. Anaesthetized male Sprague-Dawley rats underwent 30 min of bilateral renal ischaemia, and biphasic effects of pretreatment with DPCPX at 4 and 24 h reperfusion were studied on the kidney injury. Pretreatment with DPCPX attenuated at 4 h but augmented at 24 h reperfusion the renal ischaemia-induced histological damage, reductions in creatinine clearance, urea excretion and free-water reabsorption, and increases in bicarbonate excretion and tissue malondialdehyde. The DPCPX increased tumour necrosis factor-alpha expression and migration of lymphocytes in the postischaemic kidney at both time points, but with a different pattern; lymphocytes mostly aggregated in cortical periarterial spaces at 4 h reperfusion but had infiltrated into the interstitium at 24 h reperfusion. In conclusion, A(1)AR activation contributes to ischaemia-induced acute kidney injury during the early hours of reperfusion by causing a greater reduction in renal haemodynamics and by elevating tubular energy expenditure, which overcome its anti-inflammatory effect. However, its anti-inflammatory actions are exerted by reducing lymphocyte infiltration and cytokine production that begins to dominate from 4 to 24 h of reperfusion, which is reflected in attenuation of renal structural and functional disruption.
机译:我们以前曾报道,用拮抗剂8-环戊基-1,3-二丙基黄嘌呤(DPCPX)选择性阻断A(1)-腺苷受体(A(1)AR)对肾脏缺血诱导的结构和功能具有保护作用在4小时的再灌注期间中断。相反,多项研究表明,肾脏缺血前内源性和外源性A1AR激活通过减少炎症,坏死和凋亡的机制,在再灌注后24小时具有肾脏保护作用。在这项研究中,我们调查了潜在的机制,这种双相作用的A(1)AR在肾脏缺血-再灌注损伤中。麻醉的雄性Sprague-Dawley大鼠经历了30分钟的双侧肾脏缺血,并且研究了DPCPX预处理在再灌注4和24 h时对肾脏损伤的双相作用。 DPCPX预处理在4 h时减弱,但在24 h再灌注时增强,肾脏缺血引起的组织学损伤,肌酐清除率降低,尿素排泄和自由水重吸收减少,碳酸氢根排泄和组织丙二醛增加。 DPCPX在两个时间点均增加了缺血后肾脏中肿瘤坏死因子-α的表达和淋巴细胞的迁移,但模式不同;淋巴细胞在再灌注4 h时大部分聚集在皮质动脉周围空间,但在再灌注24 h时已渗入间质。总之,A(1)AR激活通过导致肾脏血流动力学的更大降低和肾小管能量消耗的增加,从而克服了其抗炎作用,从而在缺血再灌注的早期阶段导致了缺血诱导的急性肾脏损伤。然而,它的抗炎作用是通过减少淋巴细胞浸润和细胞因子产生而发挥的,这种作用从再灌注的4到24小时开始占主导地位,这反映在肾结构和功能破坏的减弱上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号